Skip to main content
Top
Published in: BMC Pulmonary Medicine 1/2021

Open Access 01-12-2021 | Bronchoscopy | Research article

Feasibility and long-term safety of Ho:YAG laser lithotripsy in broncholithiasis patients

Authors: Yuan Cheng, Guangfa Wang, Wei Zhang, Hong Zhang, Xi Wang

Published in: BMC Pulmonary Medicine | Issue 1/2021

Login to get access

Abstract

Background

Treatment of broncholithiasis is complex, especially in the case of a large or transbronchial broncholith. Holmium-yttrium aluminum garnet (Ho:YAG) laser lithotripsy may be a useful treatment in broncholithiasis; however, as it is not yet common practice, the optimal parameters are unknown.

Methods

We performed a single-center retrospective analysis of the clinical data of 13 broncholithiasis patients who underwent Ho:YAG laser lithotripsy from May 2012 to October 2018.

Results

For the 13 patients (2 males and 11 females), Ho:YAG laser lithotripsy was performed 17 times, in total. All procedures were performed under general anesthesia with rigid bronchoscopy. We initially set the Ho:YAG laser to a pulse frequency of 5 Hz and a pulse energy of 0.8 J, gradually increasing these as required. The pulse frequency range we employed was 5–15 Hz, and the pulse energy range was 0.8–1.6 J. All broncholiths were successfully extracted after lithotripsy, and all symptoms improved. Hemoptysis, bronchial esophageal fistula, and pneumonia were the most common complications; however, there were no long-term complications.

Conclusions

Ho:YAG laser lithotripsy is an effective and safe treatment for broncholithiasis, over a long-term follow up.
Literature
1.
go back to reference Lee T, Woods C, O’Hagan A. Broncholithiasis from histoplasmosis in a pediatric patient: case reports and review of literature. J Pediatric Infect Dis Soc. 2013;2(1):76–9.CrossRef Lee T, Woods C, O’Hagan A. Broncholithiasis from histoplasmosis in a pediatric patient: case reports and review of literature. J Pediatric Infect Dis Soc. 2013;2(1):76–9.CrossRef
2.
go back to reference Alshabani K, Ghosh S, Arrossi AV, Mehta AC. Broncholithiasis—a review. Chest. 2019;156(3):445–55.CrossRef Alshabani K, Ghosh S, Arrossi AV, Mehta AC. Broncholithiasis—a review. Chest. 2019;156(3):445–55.CrossRef
3.
go back to reference Krishnan S, Kniese CM, Mankins M, Heitkamp DE, Sheski FD, Kesler KA. Management of broncholithiasis. J. Thorac. Dis. 2018;1(1). Krishnan S, Kniese CM, Mankins M, Heitkamp DE, Sheski FD, Kesler KA. Management of broncholithiasis. J. Thorac. Dis. 2018;1(1).
4.
go back to reference Jin Y-X, Jiang G-N, Jiang L, Ding J-A. Diagnosis and treatment evaluation of 48 cases of broncholithiasis. Thorac Cardiovasc Surg. 2014;64(05):450–5.CrossRef Jin Y-X, Jiang G-N, Jiang L, Ding J-A. Diagnosis and treatment evaluation of 48 cases of broncholithiasis. Thorac Cardiovasc Surg. 2014;64(05):450–5.CrossRef
5.
go back to reference Ferguson JS, Rippentrop JM, Fallon B, Ross AF, McLennan G. Management of obstructing pulmonary broncholithiasis with three-dimensional imaging and holmium laser lithotripsy. Chest. 2006;130(3):909–12.CrossRef Ferguson JS, Rippentrop JM, Fallon B, Ross AF, McLennan G. Management of obstructing pulmonary broncholithiasis with three-dimensional imaging and holmium laser lithotripsy. Chest. 2006;130(3):909–12.CrossRef
6.
go back to reference Miks VM, Kvale PA, Riddle JM, Lewis JW Jr. Broncholith removal using the YAG laser. Chest. 1986;90(2):295–7.CrossRef Miks VM, Kvale PA, Riddle JM, Lewis JW Jr. Broncholith removal using the YAG laser. Chest. 1986;90(2):295–7.CrossRef
7.
go back to reference Snyder RW, Unger M, Sawicki RW. Bilateral partial bronchial obstruction due to broncholithiasis treated with laser therapy. Chest. 1998;113(1):240–2.CrossRef Snyder RW, Unger M, Sawicki RW. Bilateral partial bronchial obstruction due to broncholithiasis treated with laser therapy. Chest. 1998;113(1):240–2.CrossRef
8.
go back to reference McCaughan JS, Heinzmann HG, McMahon D. Impacted broncholiths removed with the holmium: YAG laser. Lasers Surg Med. 1996;19(2):230–2.CrossRef McCaughan JS, Heinzmann HG, McMahon D. Impacted broncholiths removed with the holmium: YAG laser. Lasers Surg Med. 1996;19(2):230–2.CrossRef
9.
go back to reference Agmy GM, Wafy SM, Mohamed SAA, Gad YA, Mustafa H, El-Aziz A. Bronchial and nonbronchial systemic artery embolization in management of hemoptysis: experience with 348 patients. ISRN Vasc Med. 2013;2013:1–7.CrossRef Agmy GM, Wafy SM, Mohamed SAA, Gad YA, Mustafa H, El-Aziz A. Bronchial and nonbronchial systemic artery embolization in management of hemoptysis: experience with 348 patients. ISRN Vasc Med. 2013;2013:1–7.CrossRef
10.
go back to reference Chen M, Kwaku A, Chen Y, Huang X, Tan H, Wen S. Gender and regional disparities of tuberculosis in Hunan, China. Int J Equity Health. 2014;13(1):32.CrossRef Chen M, Kwaku A, Chen Y, Huang X, Tan H, Wen S. Gender and regional disparities of tuberculosis in Hunan, China. Int J Equity Health. 2014;13(1):32.CrossRef
11.
go back to reference Schurz H, Salie M, Tromp G, Hoal EG, Kinnear CJ, Möller M. The X chromosome and sex-specific effects in infectious disease susceptibility. Hum Genomics. 2019;13(1):2.CrossRef Schurz H, Salie M, Tromp G, Hoal EG, Kinnear CJ, Möller M. The X chromosome and sex-specific effects in infectious disease susceptibility. Hum Genomics. 2019;13(1):2.CrossRef
12.
go back to reference Fontanilla J-M, Barnes A, von Reyn FC. Current diagnosis and management of peripheral tuberculous lymphadenitis. Clin Infect Dis. 2011;53(6):555–62.CrossRef Fontanilla J-M, Barnes A, von Reyn FC. Current diagnosis and management of peripheral tuberculous lymphadenitis. Clin Infect Dis. 2011;53(6):555–62.CrossRef
13.
go back to reference Mekonnen D, Derbie A, Abeje A, Shumet A, Nibret E, Biadglegne F, Munshae A, Bobosha K, Wassie L, Berg S, et al. Epidemiology of tuberculous lymphadenitis in Africa: a systematic review and meta-analysis. PLoS ONE. 2019;14(4):e0215647.CrossRef Mekonnen D, Derbie A, Abeje A, Shumet A, Nibret E, Biadglegne F, Munshae A, Bobosha K, Wassie L, Berg S, et al. Epidemiology of tuberculous lymphadenitis in Africa: a systematic review and meta-analysis. PLoS ONE. 2019;14(4):e0215647.CrossRef
14.
go back to reference Patel SN, Rosenkranz L, Hooks B, Tarnasky PR, Raijman I, Fishman DS, Sauer BG, Kahaleh M. Holmium-yttrium aluminum garnet laser lithotripsy in the treatment of biliary calculi using single-operator cholangioscopy: a multicenter experience (with video). Gastrointest Endosc. 2014;79(2):344–8.CrossRef Patel SN, Rosenkranz L, Hooks B, Tarnasky PR, Raijman I, Fishman DS, Sauer BG, Kahaleh M. Holmium-yttrium aluminum garnet laser lithotripsy in the treatment of biliary calculi using single-operator cholangioscopy: a multicenter experience (with video). Gastrointest Endosc. 2014;79(2):344–8.CrossRef
15.
go back to reference Ventimiglia E, Doizi S, Kovalenko A, Andreeva V, Traxer O. Effect of temporal pulse shape on urinary stone phantom retropulsion rate and ablation efficiency using holmium:YAG and super-pulse thulium fibre lasers. BJU Int. 2020. Ventimiglia E, Doizi S, Kovalenko A, Andreeva V, Traxer O. Effect of temporal pulse shape on urinary stone phantom retropulsion rate and ablation efficiency using holmium:YAG and super-pulse thulium fibre lasers. BJU Int. 2020.
16.
go back to reference Kronenberg P, Traxer O. In vitro fragmentation efficiency of holmium: yttrium-aluminum-garnet (YAG) laser lithotripsy–a comprehensive study encompassing different frequencies, pulse energies, total power levels and laser fibre diameters. BJU Int. 2014;114(2):261–7.CrossRef Kronenberg P, Traxer O. In vitro fragmentation efficiency of holmium: yttrium-aluminum-garnet (YAG) laser lithotripsy–a comprehensive study encompassing different frequencies, pulse energies, total power levels and laser fibre diameters. BJU Int. 2014;114(2):261–7.CrossRef
Metadata
Title
Feasibility and long-term safety of Ho:YAG laser lithotripsy in broncholithiasis patients
Authors
Yuan Cheng
Guangfa Wang
Wei Zhang
Hong Zhang
Xi Wang
Publication date
01-12-2021
Publisher
BioMed Central
Published in
BMC Pulmonary Medicine / Issue 1/2021
Electronic ISSN: 1471-2466
DOI
https://doi.org/10.1186/s12890-021-01407-8

Other articles of this Issue 1/2021

BMC Pulmonary Medicine 1/2021 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.